Scinai Immunotherapeutics Financial Overview
Scinai Immunotherapeutics's market cap is currently $600.08K. The company's EPS TTM is $-4.742; its P/E ratio is -0.06; Scinai Immunotherapeutics is scheduled to report earnings on December 2, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
